Gland Pharma gets U.S. FDA nod for Angiotensin II Acetate Injection
It is the exclusive first-to-file and consequently eligible for 180 days of generic drug exclusivity, Gland Pharma said on Wednesday, announcing U.S. FDA approval for its abbreviated new drug application related to Angiotensin II Acetate Injection 2.5 mg/mL.
Bioequivalent and therapeutically equivalent to reference listed drug Giapreza of La Jolla Pharma LLC, the product had U.S. sales of around $58 million for the 12 months ended March 2025, Gland Pharma said citing IQVIA numbers. The company's shares closed 1.88% higher at ₹1,623.70 apiece on the BSE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
27 minutes ago
- Hans India
US tariff-hit stocks weigh on key indices
Mumbai: Equity benchmark indices-Sensex and Nifty- declined sharply for the second straight session on Friday, tracking deep losses in pharma, metal, and IT stocks amid trade-related concerns and widespread selling pressure in global markets. Besides, persistent selling by foreign investors added to the gloom, according to experts. In a volatile trade, the 30-share BSE Sensex tumbled 585.67 points or 0.72 per cent to settle at 80,599.91. During the day, it dropped 690.01 points or 0.84 per cent to 80,495.57. As many as 2,712 stocks declined while 1,306 advanced and 151 remained unchanged on the BSE. The 50-share NSE Nifty declined 203 points or 0.82 per cent to 24,565.35. 'The benchmark index Nifty wrapped up its fifth consecutive week in the red -- its longest losing streak since August 2023, raising eyebrows across the making multiple attempts to scale up, the index has struggled to hold ground, only to be met with selling pressure each time. The long upper wicks are a telling story — bulls tried, but bears had the final say,' Sudeep Shah, Head - Technical Research and Derivatives at SBI Securities, said.
Mint
an hour ago
- Mint
Sri Lotus Developers IPO: Focus shifts on allotment date after strong subscription status; GMP, how to check status
Sri Lotus Developers IPO Allotment: The initial public offering (IPO) of real estate company Sri Lotus Developers garnered strong demand. As the bidding period has ended, investors now focus on Sri Lotus Developers IPO allotment date, which is likely today. However, in case of any delay, share allotment can be expected on Monday. The public issue was open from July 30 to August 1. Sri Lotus Developers IPO allotment date is expected to be 2 August 2025, Saturday or on 4 August 2025, Monday, and the Sri Lotus Developers IPO listing date is likely on August 6, 2025. The company will finalise the Sri Lotus Developers IPO allotment status soon. Once the basis of share allotment is finalised, the company will then credit the equity shares into the demat accounts of the eligible allotment holders on August 5 and initiate refunds on the same day. Applicants can check Sri Lotus Developers IPO allotment status online through the websites of BSE and NSE along with the official portal of the IPO registrar. Kfin Technologies is the Sri Lotus Developers IPO registrar. To do Sri Lotus Developers IPO allotment status check online, the following steps must be followed. Here are the steps to check Sri Lotus Developers IPO allotment status online: Step 2] Select 'Equity' in the Issue Type Step 3] Choose 'Sri Lotus Developers Limited' in the Issue Name dropdown menu Step 4] Enter either Application No. or PAN Step 5] Verify by ticking on 'I am not robot' and click on 'Search' Your Sri Lotus Developers IPO allotment status will be displayed on the screen. Step 2] Select 'Equity and SME IPO bids' Step 3] Choose 'Sri Lotus Developers Limited' from the Issue Name dropdown menu Step 4] Enter your PAN and Application Number Your Sri Lotus Developers IPO allotment status will be displayed on the screen. Step 1] Visit IPO registrar's website on this link - Step 2] Choose 'Sri Lotus Developers Limited' in the Select IPO dropdown menu Step 3] Select either Application No, Demat Account, or PAN Step 4] Enter the details as per the option selected Step 5] Enter the Captcha code and click on Submit Your Sri Lotus Developers IPO allotment status will be displayed on the screen. The trends for Sri Lotus Developers shares in the unlisted market remains bullish with a higher grey market premium (GMP). Sri Lotus Developers IPO GMP today is ₹ 44 per share, market experts said. This means that in the grey market, Sri Lotus Developers shares are trading higher by ₹ 44 than their issue price. Considering the Sri Lotus Developers IPO GMP today, the estimated listing price of Sri Lotus Developers shares would be ₹ 194 apiece, which is at a premium of 29.33% to the IPO price of ₹ 150 per share. Sri Lotus Developers launched its IPO on July 30, which closed on August 1. Sri Lotus Developers IPO allotment date is likely August 4, and the tentative IPO listing date is August 6. The equity shares of the company will be listed on both the stock exchanges, BSE and NSE. The company raised ₹ 792.00 crore from the IPO at a fixed price band of ₹ 150 per share. Sri Lotus Developers IPO was entirely a fresh issue of 5.28 crore equity shares. Sri Lotus Developers IPO was subscribed 69.14 times in total as the issue received bids for 274.18 crore equity shares as against 3.96 crore shares on the offer, NSE subscription status data showed. The IPO was subscribed 20.28 times in the Retail investors category, and 57.71 times in the Non-Institutional Investors segment. The Qualified Institutional Buyers (QIB) category received 163.90 times subscription. Motilal Oswal Investment Advisors is the book-running lead manager, while Kfin Technologies is the Sri Lotus Developers IPO registrar. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
an hour ago
- Mint
NSDL IPO allotment date in focus after strong subscription status; GMP, how to check application status online
NSDL IPO Allotment: The initial public offering (IPO) of National Securities Depository Limited (NSDL) received strong demand from investors across categories during its subscription period which ended on Friday. The focus now shifts towards NSDL IPO allotment date which is likely today. The public offer was open from July 30 to August 1. NSDL IPO allotment date is expected today. However, in case of delay, the NSDL IPO allotment is expected to be 4 August 2025, and the IPO listing date is likely August 6. NSDL shares will be listed on BSE. The company will soon finalise the basis of NSDL IPO allotment status. Once the NSDL share allotment status is fixed, the company will credit the equity shares into the demat accounts of the eligible allotment holders on August 5, and initiate refunds to unsuccessful investors on the same day. Investors can check NSDL IPO allotment status online through the websites of BSE and the IPO registrar. MUFG Intime India (Link Intime) is the NSDL IPO registrar. In order to do NSDL IPO allotment status online check, investors must follow a few simple steps mentioned below. Here's how to check NSDL IPO allotment status online. Step 2] Select 'Equity' in the Issue Type Step 3] Choose 'National Securities Depository Limited' in the Issue Name dropdown menu Step 4] Enter either Application No. or PAN Step 5] Verify by ticking on 'I am not robot' and click on 'Search' Your NSDL IPO allotment status will be displayed on the screen. Step 2] Choose 'National Securities Depository Limited' in the Select Company dropdown menu Step 3] Select among PAN, App. No., DP ID or Account No. Step 4] Enter the details as per the option selected Your NSDL IPO allotment status will be displayed on the screen. NSDL shares are available at a strong premium in the grey market. According to market experts, NSDL IPO GMP today is ₹ 136 per share. This means that in the grey market, NSDL shares are trading higher by ₹ 136 than their issue price. NSDL IPO GMP today signals that the estimated listing price of NSDL shares would be ₹ 936 apiece, which is at 17% premium to the IPO price of ₹ 800 per share. The bidding for the public issue commenced on July 30 and concluded on August 1. NSDL IPO allotment date is likely 4 August 2025, Monday, and the tentative IPO listing date is August 6. NSDL shares will be listed on BSE. NSDL IPO price band was ₹ 800 per share. The company raised ₹ 4,011.60 crore from the book-building issue which was entirely an offer-for-sale (OFS) of 5.01 crore equity shares. NSDL IPO has been subscribed 41.01 times in total as the issue received bids for 144.03 crore equity shares as against 3.51 crore shares on the offer, according to the subscription data on NSE. The Retail investors category was subscribed 7.73 times, while the Non Institutional Investors (NII) portion was booked 34.98 times. The Qualified Institutional Buyers (QIBs) category received 103.97 times the subscription. ICICI Securities is the book-running lead manager, while MUFG Intime India (Link Intime) is the NSDL IPO registrar. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
